UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.
Humana Inc.
Centene Corporation
Johnson & Johnson
The Cigna Group
Molina Healthcare, Inc.
Alkermes Inc. plc
Medpace Holdings, Inc. Common Stock
Elevance Health, Inc.
CVS HEALTH CORPORATION
HCA Healthcare, Inc.
The chart shows the growth of an initial investment of $10,000 in UNITEDHEALTH GROUP INCORPORATED (Delaware), comparing it to the performance of the S&P 500 index.
All prices have been adjusted for splits and dividends.
UNITEDHEALTH GROUP INCORPORATED (Delaware) (UNH) has returned -16.21% so far this year and -46.00% over the past 12 months. Looking at the last ten years, UNH has achieved an annualized return of 7.83%, underperforming the Benchmark (SPY), which averaged 12.23% per year.
The table below presents the monthly returns of UNITEDHEALTH GROUP INCORPORATED (Delaware) (UNH) with color gradation from worst to best to easily spot seasonal factors.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -13.29% | 2.53% | -6.10% | 1.11% | ||||||||
| 2025 | 6.79% | -12.37% | 10.41% | -21.74% | -26.60% | 2.92% | -20.01% | 23.65% | 12.00% | -0.68% | -2.76% | 0.90% |
| 2024 | -2.87% | -2.99% | 1.08% | -2.18% | 3.36% | 3.06% | 13.70% | 2.25% | -1.32% | -3.50% | 7.98% | -17.61% |
| 2023 | -4.94% | -4.80% | -0.22% | 1.42% | -1.49% | -1.47% | 5.91% | -6.09% | 5.26% | 5.94% | 4.34% | -4.35% |
| 2022 | -5.49% | 0.18% | 8.30% | -0.42% | -2.75% | 3.07% | 5.86% | -4.23% | -2.75% | 9.48% | -1.30% | -4.02% |
| 2021 | -5.08% | -0.84% | 11.28% | 7.15% | 2.72% | -3.21% | 2.53% | 0.65% | -6.19% | 17.59% | -3.81% | 10.87% |
| 2020 | -7.32% | -7.33% | -3.09% | 22.53% | 5.71% | -2.98% | 2.35% | 2.95% | 0.52% | -2.48% | 7.58% | 1.71% |
| 2019 | 10.29% | -9.78% | 1.52% | -6.66% | 3.75% | 1.04% | 1.24% | -6.10% | -6.22% | 15.29% | 10.19% | 4.33% |
| 2018 | 7.13% | -3.87% | -5.18% | 8.21% | 1.90% | 0.66% | 3.36% | 4.83% | -0.73% | -2.21% | 7.01% | -11.97% |
| 2017 | 0.60% | 1.62% | -1.63% | 6.23% | 0.10% | 5.48% | 2.96% | 2.84% | -1.97% | 6.93% | 7.82% | -3.68% |
| 2016 | 2.32% | 0.80% | 5.70% | 1.45% | -5.14% | 2.32% | 1.42% | 11.88% | 0.58% |
The charts below present risk-adjusted performance metrics for UNITEDHEALTH GROUP INCORPORATED (Delaware) (UNH) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.
The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.
These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.
The chart below shows the rolling Sharpe ratio of UNH compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.
The current UNITEDHEALTH GROUP INCORPORATED (Delaware) volatility is 1.64%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses.
Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.
The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities And Equity (USD) | 309.58B | 298.28B | 273.72B | 245.71B | 212.21B | 197.29B | 173.89B | 152.22B | 139.06B | 122.81B | 111.38B | 86.38B | 81.88B | 80.89B | 67.89B | 59.05B |
| Temporary Equity (USD) | 1.61B | 4.32B | 4.50B | 4.90B | 1.43B | 2.21B | 1.73B | 1.91B | 2.19B | 2.01B | 1.74B | 1.39B | 1.18B | 2.12B | - | - |
| Equity Attributable To Parent (USD) | 94.11B | 92.66B | 88.76B | 77.77B | 71.76B | 65.49B | 57.62B | 51.70B | 47.78B | 38.27B | 33.83B | 32.45B | 32.15B | 31.18B | 28.29B | 23.61B |
| Equity Attributable To Noncontrolling Interest (USD) | 5.98B | 5.61B | 5.67B | 3.68B | 3.29B | 2.84B | 2.82B | 2.62B | 2.06B | -97.00M | -105.00M | - | - | - | - | - |
| Equity (USD) | 100.09B | 98.27B | 94.42B | 81.45B | 75.05B | 68.33B | 60.44B | 54.32B | 49.83B | 38.18B | 33.73B | 32.45B | 32.15B | 31.18B | 28.29B | 23.61B |
| Redeemable Noncontrolling Interest (USD) | 1.61B | 4.32B | 4.50B | 4.90B | 1.43B | 2.21B | 1.73B | 1.91B | 2.19B | 2.01B | 1.74B | 1.39B | 1.18B | 2.12B | - | - |
| Noncurrent Liabilities (USD) | 92.99B | 91.92B | 75.75B | 70.12B | 57.44B | 54.33B | 49.95B | 42.79B | 36.57B | 33.37B | 33.02B | 21.92B | 20.68B | 20.47B | 15.68B | 13.28B |
| Current Liabilities (USD) | 114.90B | 103.77B | 99.05B | 89.24B | 78.29B | 72.42B | 61.78B | 53.21B | 50.46B | 49.25B | 42.90B | 30.62B | 27.88B | 27.12B | 23.92B | 22.16B |
| Liabilities (USD) | 207.88B | 195.69B | 174.80B | 159.36B | 135.73B | 126.75B | 111.73B | 95.99B | 87.04B | 82.62B | 75.92B | 52.54B | 48.56B | 47.59B | 39.60B | 35.44B |
| Other Non-current Assets (USD) | 187.76B | 178.68B | 168.64B | 152.11B | 131.44B | 124.09B | 112.20B | 95.75B | 86.47B | 74.49B | 66.49B | 54.74B | 53.65B | 51.21B | 42.23B | 36.32B |
| Intangible Assets (USD) | 20.47B | 23.27B | 15.19B | 14.40B | 10.04B | 10.86B | 10.35B | 9.33B | 8.49B | 8.54B | 8.39B | 3.67B | 3.84B | 4.68B | 2.80B | 2.38B |
| Fixed Assets (USD) | 10.76B | 10.55B | 11.45B | 10.13B | 8.97B | 8.63B | 8.70B | 8.46B | 7.01B | 5.90B | 4.86B | 4.42B | 4.01B | 3.94B | 2.52B | 2.14B |
| Noncurrent Assets (USD) | 219.00B | 212.50B | 195.28B | 176.64B | 150.45B | 143.57B | 131.26B | 113.53B | 101.97B | 88.93B | 79.74B | 62.83B | 61.50B | 59.83B | 47.54B | 40.85B |
| Other Current Assets (USD) | 87.28B | 81.98B | 75.64B | 65.57B | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory (USD) | 3.30B | 3.80B | 2.80B | 3.50B | - | - | - | - | - | - | - | - | - | - | - | - |
| Current Assets (USD) | 90.58B | 85.78B | 78.44B | 69.07B | 61.76B | 53.72B | 42.63B | 38.69B | 37.08B | 33.88B | 31.64B | 23.56B | 20.38B | 21.05B | 20.35B | 18.20B |
| Assets (USD) | 309.58B | 298.28B | 273.72B | 245.71B | 212.21B | 197.29B | 173.89B | 152.22B | 139.06B | 122.81B | 111.38B | 86.38B | 81.88B | 80.89B | 67.89B | 59.05B |
The article recommends three dividend stocks for long-term investors: Philip Morris International, which is expanding into smoke-free nicotine products with strong growth; Pfizer, offering a high 6.2% dividend yield despite being down 55% from highs and facing headwinds in obesity drugs; and UnitedHealth Group, a health insurer down 58% from highs but expected to rebound with strong earnings growth driven by an aging U.S. population.
The article examines the three highest-yielding stocks in the Dow Jones—Verizon (5.6% yield), Chevron (3.3% yield), and UnitedHealth Group (3.3% yield)—concluding that none represent a clear buying opportunity. Verizon offers reliable income but faces high debt and slow dividend growth; Chevron is well-managed but may be overpriced due to temporary oil price spikes; UnitedHealth is an industry leader but faces regulatory headwinds and earnings volatility.
The Schwab U.S. Dividend Equity ETF (SCHD) completed its annual reconstitution, adding UnitedHealth and Abbott Laboratories while removing AbbVie. These changes increased the fund's healthcare sector allocation from 15.4% to 18.9%, making it the second-largest sector weighting. The new holdings have a higher average dividend growth rate (9.4% vs 8.6%), which should generate more income and potentially higher total returns for investors over time.
The article recommends two healthcare stocks for long-term investors with $500 to invest. Pfizer, trading at 9x forward earnings, has faced revenue declines post-COVID but is positioning for growth through oncology acquisitions and entry into the obesity drug market. UnitedHealth Group, trading at 15x forward earnings, struggled with underestimated healthcare costs but has implemented cost-cutting measures and AI optimization to recover.
The article analyzes whether defensive sectors (Utilities, Consumer Staples, and Health Care) are signaling market trouble amid rising volatility. Utilities show strong relative strength with an uptrend, Consumer Staples are testing key support levels, and Health Care exhibits a bearish double top pattern. The author cautions that while defensive strength can indicate market weakness, current signals are mixed and traders should monitor these sectors alongside broader market analysis.
The global dental insurance market is projected to grow from USD 118.77 billion in 2026 to USD 198.31 billion by 2032, with a CAGR of 8.72%. Growth is driven by digital transformation, evolving care models, and regulatory shifts. Key trends include provider consolidation, value-based care models, and increased investment in analytics and digital-first distribution channels.
ATI Advisory announced that Bill Hanna, former Wisconsin Medicaid Director, has joined as Practice Director of Payer Strategy and Program Design. Hanna brings extensive experience in Medicaid policy, managed care delivery, and operational transformation from previous roles at UnitedHealthcare and the District of Columbia Department of Health Care Finance. His appointment reflects ATI's expansion in payer strategy services to support state Medicaid programs and managed care organizations navigating fiscal pressures and regulatory complexity.
Warren Buffett's retirement marks a significant warning to investors as Berkshire Hathaway has been a net seller of stocks for 13 consecutive quarters, totaling $187 billion in sales. With the S&P 500's CAPE ratio at 39.8 in February 2026—the highest since the dot-com crash—historical data suggests the index could decline by 30% over the next three years if valuations don't improve or earnings don't grow substantially.
Billionaire Ole Andreas Halvorsen, who manages $37 billion at Viking Global Investors, recently purchased shares in two recovery story stocks: Carnival Corp., the world's largest cruise operator, and UnitedHealth Group, the top U.S. health insurer. Carnival has recovered significantly from pandemic losses and is trading at reasonable valuations with strong demand, while UnitedHealth is earlier in its turnaround journey after facing healthcare cost pressures and regulatory probes, but is taking aggressive steps to improve performance.
The global healthcare predictive analytics market is projected to grow from USD 20.57 billion in 2025 to USD 140.02 billion by 2035, with a CAGR of 21.14%. Growth is driven by increasing EHR adoption, government mandates for healthcare digitalization, value-based care adoption, and emphasis on reducing hospital readmissions. The U.S. market alone is expected to reach USD 57.64 billion by 2035. Asia Pacific is experiencing the fastest growth at 23.15% CAGR, while North America maintains the largest market share at 44.72%.